The GLP-1 receptor agonist dose should be lowered and patients should be encouraged to increase meal size and frequency
Users who notice hair improvements typically see them at the 2 to 3 month mark
7:14531 (2017) Siddiqui SA, Asif Z, Murid M, Fernando I, Adli DN, Blinov AV, Golik AB, Nugraha WS, Ibrahim SA, Jafari SM
The gastrointestinal side effects commonly associated with semaglutideparticularly nausea, vomiting, and diarrheacan lead to reduced fluid intake and increased fluid losses
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
Perspective and future directions Development of the first GLP-1R/ GcgR co-agonists has prompted the search for novel multi-agonists of differentiated mechanisms that offer unprecedented potential in the treatment of obesity